

Next Unicorns: Developing drugs to extend dog lifespans with Loyal CEO Celine Halioua | E1799
4 snips Aug 30, 2023
Celine Halioua, CEO and founder of Loyal, explores groundbreaking ways to extend dog lifespans through innovative drug developments. With her background in neuroscience, she discusses the benefits of canine-specific medications and the parallels between dog and human aging. The episode delves into the challenges of developing effective treatments while addressing genetic issues stemming from selective breeding. Celine also shares insights on the ethics of veterinary research and the critical role of continued advancements in pet health for overall well-being.
AI Snips
Chapters
Transcript
Episode notes
Life Extension Dream
- Life extension is a long-held human dream, pursued by various groups throughout history.
- Startups now use biotech, AI, and big data to fight aging, with Loyal focusing on dogs as a starting point.
Loyal's Origin
- Celine Halioua switched from art school to neuroscience after realizing adults couldn't solve age-related diseases.
- Inspired by the link between dog size and lifespan, she started Loyal, a company focused on dog life extension.
Why Dogs?
- Dogs share environments with humans, making them good models for human aging.
- They experience similar age-related diseases and environmental factors, making them better than chimpanzees for studying human aging.